Extensive O.R. Procedures Unrelated to Principal Diagnosis DRG 981 Reimbursement

Summary & Overview

Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCC: Inpatient Reimbursement Overview

DRG 981 applies to admissions with extensive operating room procedures unrelated to the principal diagnosis when a Major Complication or Comorbidity is present; it captures high-resource inpatient surgical encounters. This Diagnosis-Related Group matters for inpatient reimbursement because the unrelated extensive procedures and the Major Complication or Comorbidity drive higher payment classification to account for increased hospital resource utilization.

Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCCDRG Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCCDRG 981Diagnosis-Related GroupInpatient ReimbursementMedicareSurgical ProceduresPostoperative ComplicationsHospital CodingClinical Documentation

DRG 981 Overview

DRG 981 covers hospital stays involving extensive operating room procedures that are unrelated to the principal diagnosis and that include a Major Complication or Comorbidity. These cases typically involve significant additional surgical intervention occurring during the same inpatient episode, increasing resource use and clinical complexity. This Diagnosis-Related Group matters for Medicare payment because the presence of a Major Complication or Comorbidity elevates reimbursement to reflect higher expected costs of care. Accurate coding of procedures and comorbid conditions is critical to align payment with the intensity of services provided.

National Payment Rates

Across commercial payers the observed rates for DRG 981 span from about $370 up to $170K, with payer medians ranging from roughly $42K to $83K; the widest spread is between the BCBS minimums/low-percentiles and Anthem’s maximum of $170K as shown in the table and chart below. Aetna and Cigna display medians near the top of the commercial range, while BCBS shows the lowest floor values. Use the table and chart below to compare payer-specific percentiles and distributions.

Mean Rates by Payer — National — DRG 981

State Payment Rates

State: Alaska1 / 49

Alaska Benchmarks

Payer means in Alaska span from $73K to $110K, reflecting a wide rate range across payers. Cigna sits at the high end with a mean of $110K, while Anthem and Blue Cross Blue Shield are tied at $73K. This distribution shows a notable high-side deviation from national averages for Cigna. See the table and chart below for full payer detail.

Key Insights for Alaska

Highest payer: Cigna at $110K mean; Lowest payers: Anthem and Blue Cross Blue Shield (BCBS) both at $73K mean.
Alaska’s mean rates range from $73K to $110K, with Cigna notably above national means for its peers, creating a meaningful upward deviation at the top end.

Clinical Trials

Acute perioperative safety and complication reduction trials: randomized or prospective cohort studies testing protocols to reduce intraoperative and immediate postoperative complications (bleeding, infection, thromboembolism, organ injury) in patients undergoing extensive operating room procedures that are unrelated to the hospital admission’s principal diagnosis. These studies enroll complex surgical patients who require unplanned or staged major procedures during the same hospitalization, often with multiple comorbidities and MCCs, and evaluate process changes (enhanced monitoring, blood management bundles, antimicrobial prophylaxis timing) to lower morbidity. Results are relevant to providers for improving clinical pathways and to payers because reducing complications shortens length of stay and reduces high-cost resource use that drives DRG payment variance.
Comparative effectiveness and resource utilization studies of surgical approach and timing: observational comparative studies or pragmatic trials comparing different operative strategies (e.g., open versus minimally invasive approaches, single-stage versus staged procedures) or timing of elective extensive procedures performed while admitted for an unrelated principal diagnosis. These trials focus on heterogeneous inpatients with major comorbid conditions who require extensive OR interventions on top of their primary admission issue, assessing outcomes including complication rates, ICU utilization, readmissions, and total hospital costs. Findings inform clinical decision-making about which approaches yield better outcomes and lower inpatient resource use, helping payers and hospitals optimize case selection, DRG cost management, and allocation of high-acuity OR/ICU capacity.
Post-discharge outcomes and readmission prevention studies: longitudinal cohort studies and intervention trials that follow patients after discharge to measure functional recovery, complication-related readmissions, and outpatient resource consumption after extensive unrelated OR procedures during the index hospitalization. These studies enroll survivors of complex inpatient surgeries with MCCs to evaluate transitional care interventions (structured follow-up, home health integration, remote monitoring) and risk prediction tools to prevent preventable readmissions and late surgical complications. This research is important to providers for designing discharge plans and to payers because reducing avoidable readmissions and post-acute utilization directly affects total episode cost and quality metrics tied to reimbursement.

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis with CC: Inpatient Reimbursement Overview

982-EXTENSIVE-O-R-PROCEDURES-UNRELATED-TO-PRINCIPAL-DIAGNOSIS-WITH-CC

Extensive O.R. Procedures Unrelated to Principal Diagnosis with CC: Inpatient Reimbursement Overview

983-EXTENSIVE-O-R-PROCEDURES-UNRELATED-TO-PRINCIPAL-DIAGNOSIS-WITHOUT-CC-MCC

Extensive O.R. Procedures Unrelated to Principal Diagnosis without CC/MCC: Inpatient Reimbursement Overview

987-NON-EXTENSIVE-O-R-PROCEDURES-UNRELATED-TO-PRINCIPAL-DIAGNOSIS-WITH-MCC

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCC: Inpatient Reimbursement Overview

989-NON-EXTENSIVE-O-R-PROCEDURES-UNRELATED-TO-PRINCIPAL-DIAGNOSIS-WITHOUT-CC-MCC

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis without CC/MCC: Inpatient Reimbursement Overview

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Average Total Payment	Average Submitted Charges	Average Medicare Payment	Total Discharges
$43K	$200K	$38K	21K

State Payment Rates

State: Alaska1 / 49

Alaska Benchmarks

Mean Rates by Payer — Alaska — DRG 981

Key Insights for Alaska

Highest payer: Cigna at $110K mean; Lowest payers: Anthem and Blue Cross Blue Shield (BCBS) both at $73K mean.
Alaska’s mean rates range from $73K to $110K, with Cigna notably above national means for its peers, creating a meaningful upward deviation at the top end.

Clinical Trials

Acute perioperative safety and complication reduction trials: randomized or prospective cohort studies testing protocols to reduce intraoperative and immediate postoperative complications (bleeding, infection, thromboembolism, organ injury) in patients undergoing extensive operating room procedures that are unrelated to the hospital admission’s principal diagnosis. These studies enroll complex surgical patients who require unplanned or staged major procedures during the same hospitalization, often with multiple comorbidities and MCCs, and evaluate process changes (enhanced monitoring, blood management bundles, antimicrobial prophylaxis timing) to lower morbidity. Results are relevant to providers for improving clinical pathways and to payers because reducing complications shortens length of stay and reduces high-cost resource use that drives DRG payment variance.
Comparative effectiveness and resource utilization studies of surgical approach and timing: observational comparative studies or pragmatic trials comparing different operative strategies (e.g., open versus minimally invasive approaches, single-stage versus staged procedures) or timing of elective extensive procedures performed while admitted for an unrelated principal diagnosis. These trials focus on heterogeneous inpatients with major comorbid conditions who require extensive OR interventions on top of their primary admission issue, assessing outcomes including complication rates, ICU utilization, readmissions, and total hospital costs. Findings inform clinical decision-making about which approaches yield better outcomes and lower inpatient resource use, helping payers and hospitals optimize case selection, DRG cost management, and allocation of high-acuity OR/ICU capacity.
Post-discharge outcomes and readmission prevention studies: longitudinal cohort studies and intervention trials that follow patients after discharge to measure functional recovery, complication-related readmissions, and outpatient resource consumption after extensive unrelated OR procedures during the index hospitalization. These studies enroll survivors of complex inpatient surgeries with MCCs to evaluate transitional care interventions (structured follow-up, home health integration, remote monitoring) and risk prediction tools to prevent preventable readmissions and late surgical complications. This research is important to providers for designing discharge plans and to payers because reducing avoidable readmissions and post-acute utilization directly affects total episode cost and quality metrics tied to reimbursement.

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis with CC: Inpatient Reimbursement Overview

982-EXTENSIVE-O-R-PROCEDURES-UNRELATED-TO-PRINCIPAL-DIAGNOSIS-WITH-CC

Extensive O.R. Procedures Unrelated to Principal Diagnosis with CC: Inpatient Reimbursement Overview

983-EXTENSIVE-O-R-PROCEDURES-UNRELATED-TO-PRINCIPAL-DIAGNOSIS-WITHOUT-CC-MCC

Extensive O.R. Procedures Unrelated to Principal Diagnosis without CC/MCC: Inpatient Reimbursement Overview

987-NON-EXTENSIVE-O-R-PROCEDURES-UNRELATED-TO-PRINCIPAL-DIAGNOSIS-WITH-MCC

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCC: Inpatient Reimbursement Overview

989-NON-EXTENSIVE-O-R-PROCEDURES-UNRELATED-TO-PRINCIPAL-DIAGNOSIS-WITHOUT-CC-MCC

Non-Extensive O.R. Procedures Unrelated to Principal Diagnosis without CC/MCC: Inpatient Reimbursement Overview

OpenPayer

Summary & Overview

Extensive O.R. Procedures Unrelated to Principal Diagnosis with MCC: Inpatient Reimbursement Overview

DRG 981 Overview

National Payment Rates

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes

Patient Population

State Payment Rates

Alaska Benchmarks

Key Insights for Alaska

Clinical Trials

Related Codes